34441867|t|Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis.
34441867|a|Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis. Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid profile. ApoC-II mimetics reverse hypertriglyceridemia and ApoE-based peptides such as Ac-hE18A-NH2 reduce cholesterol and triglyceride (TG) levels in humans. Conversely, other classes of ApoE and ApoA-I mimetic peptides and, more recently, ApoJ and LRP1-based peptides, exhibit several anti-atherosclerotic actions in experimental models without influencing lipoprotein profile. These other mimetic peptides display at least one atheroprotective mechanism such as providing LDL stability against mechanical modification or conferring protection against the action of lipolytic enzymes inducing LDL aggregation in the arterial intima. Other anti-atherosclerotic effects exerted by these peptides also include protection against foam cell formation and inflammation, and induction of reverse cholesterol transport. Although the underlying mechanisms of action are still poorly described, the recent findings suggest that these mimetics could confer atheroprotection by favorably influencing lipoprotein function rather than lipoprotein levels. Despite the promising results obtained with peptide mimetics, the assessment of their stability, atheroprotective efficacy and tissue targeted delivery are issues currently under progress.
34441867	19	23	LRP1	Gene	4035
34441867	30	38	Peptides	Chemical	MESH:D010455
34441867	67	82	Atherosclerosis	Disease	MESH:D050197
34441867	119	127	peptides	Chemical	MESH:D010455
34441867	154	169	atherosclerosis	Disease	MESH:D050197
34441867	183	190	ApoC-II	Gene	344
34441867	195	199	ApoE	Gene	348
34441867	220	235	atherosclerotic	Disease	MESH:D050197
34441867	257	262	lipid	Chemical	MESH:D008055
34441867	272	279	ApoC-II	Gene	344
34441867	297	317	hypertriglyceridemia	Disease	MESH:D015228
34441867	322	326	ApoE	Gene	348
34441867	333	341	peptides	Chemical	MESH:D010455
34441867	370	381	cholesterol	Chemical	MESH:D002784
34441867	386	398	triglyceride	Chemical	MESH:D014280
34441867	400	402	TG	Chemical	MESH:D014280
34441867	414	420	humans	Species	9606
34441867	451	455	ApoE	Gene	348
34441867	460	466	ApoA-I	Gene	335
34441867	475	483	peptides	Chemical	MESH:D010455
34441867	504	508	ApoJ	Gene	1191
34441867	513	517	LRP1	Gene	4035
34441867	524	532	peptides	Chemical	MESH:D010455
34441867	555	570	atherosclerotic	Disease	MESH:D050197
34441867	663	671	peptides	Chemical	MESH:D010455
34441867	909	924	atherosclerotic	Disease	MESH:D050197
34441867	950	958	peptides	Chemical	MESH:D010455
34441867	1015	1027	inflammation	Disease	MESH:D007249
34441867	1054	1065	cholesterol	Chemical	MESH:D002784
34441867	Negative_Correlation	MESH:D010455	MESH:D014280
34441867	Association	MESH:D050197	344
34441867	Association	MESH:D050197	1191
34441867	Association	MESH:D008055	344
34441867	Association	MESH:D050197	348
34441867	Negative_Correlation	MESH:D014280	348
34441867	Association	MESH:D050197	335
34441867	Negative_Correlation	MESH:D010455	MESH:D050197
34441867	Association	MESH:D010455	4035
34441867	Association	MESH:D050197	4035
34441867	Negative_Correlation	MESH:D002784	MESH:D010455
34441867	Negative_Correlation	MESH:D015228	344
34441867	Association	MESH:D010455	335
34441867	Negative_Correlation	MESH:D010455	MESH:D007249
34441867	Association	MESH:D002784	348

